Quantcast
Home > Quotes > BIO

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Quote & Summary Data

BIO 
$305.44
*  
0.95
0.31%
Get BIO Alerts
*Delayed - data as of Jul. 20, 2018  -  Find a broker to begin trading BIO now
Exchange:NYSE
Industry: Capital Goods
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
337.5
Today's High / Low
$ 307.48 / $ 305
Share Volume
48,206
90 Day Avg. Daily Volume
141,059
Previous Close
$ 306.39
52 Week High / Low
$ 307.63 / $ 208.95
Market Cap
9,103,544,514
P/E Ratio
12.14
Forward P/E (1y)
49.42
Earnings Per Share (EPS)
$ 25.17
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.49

Intraday Chart

Shares Traded

Share Volume:
48,206
90 Day Avg. Daily Volume:
141,059

P/E Ratio

P/E Ratio:
12.14
Forward P/E (1y):
49.42
Earnings Per Share (EPS):
$ 25.17

Trading Range

The current last sale of $305.44 is 46.18% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 307.48 $ 307.63
 Low: $ 305 $ 208.95

ETFs with BIO as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
0.69% Principal Contrarian Value Index ETF (PVAL) N/A (N/A)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Founded in 1952 and incorporated in 1957, Bio-Rad Laboratories, Inc. (referred to in this report as "Bio-Rad," "we," "us," and "our") was initially engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical and other life science research applications. We entered the field of clinical diagnostics with the development of our first test kit based on separation techniques and materials developed for life science research. Through internal research and development efforts and acquisitions we have expanded into various markets. Today, Bio-Rad manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. As we broadened our product lines, we also expanded our geographical market.  ... More ...  

Risk Grade

Where does BIO fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info